Genetics
Home › Medical research › Fibromyalgia
Insufficient evidence

Fibromyalgia & cannabis

The 2016 Cochrane review found very-low-quality evidence from two small nabilone studies and could not draw robust conclusions about benefit in fibromyalgia. These findings do not establish that any cannabis strain treats fibromyalgia.

Sources: Cochrane: Cannabinoids for fibromyalgia (2016)

Safety & cautions

Uncertain benefit; adverse effects were more frequent with nabilone in the small studies.

Clinical research below concerns cannabis or cannabinoids, not evidence that a named cultivar treats a condition.

Help us build this responsibly

This page reflects the cited published clinical evidence, and it is a work in progress. Areto is committed to expanding and refining it as new research emerges — so it can genuinely help medical patients make informed choices. If you are a clinician, researcher, or patient with peer-reviewed sources to add, email us at genetics@areto.tech.

Areto Genetics is an educational cannabis catalog. Nothing here is medical advice, and no strain is proven to treat, cure, or prevent any disease. Cannabis affects people differently and carries real risks. Talk to a qualified healthcare provider before using cannabis for any condition — especially if you are pregnant or breastfeeding, an adolescent, taking other medications, or have a heart, liver, or psychiatric condition.